T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

Overview of attention for article published in Journal of Translational Medicine, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Dimensions has found 28 publications that cite this research output.

Article in Nature Cancer (August 2023)

Article in Nature Reviews Drug Discovery (August 2023)

Article in Frontiers in Immunology (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.